Health Care · Laboratory Analytical Instruments · Nasdaq · CIK 1411690 · FYE Dec 31 · Prices AT CLOSE 2026-07-29 (USD) — end-of-day, never a live or intraday quote
Last $1.09Day +0.00%Mkt cap $13M1Y −64.6%Off 52W high −80.2%Vol (1Y) 82.2%
Daily closing price, split-adjusted to the current basis; 3y shown of 1,967 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest9.5% of sh out |
| Days to cover8.6d |
| 13F net flow (QoQ)+1.27% |
| Top-10 13F concentration96.4% |
| Next report (est.)2026-08-12 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)$28.7M |
| Earnings (TTM)-$31.6M |
| ROE−66.2% |
| Net margin−92.6% |
| ROIC−77.9% |
| Sales growth 3Y0.8% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD−28.8% |
| 1Y−64.6% |
| 3Y−99.7% |
| 5Y−100.0% |
| Since incept. (ann.)−65.0% |
Total return through 2026-07-29 · series begins 2018-09-21. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)82.2% |
| Ann. volatility (3Y)91.9% |
| Sharpe (1Y)−0.92 |
| Sharpe (3Y)−1.64 |
| Max drawdown (1Y)−78.0% |
| Max drawdown (3Y)−99.7% |
| Beta (3Y vs SPY)1.31 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| GSA CAPITAL PARTNERS LLP | 353,363 | $413,000 | 3.19% | +4.6% |
| GEODE CAPITAL MANAGEMENT, LLC | 167,533 | $196,015 | 1.51% | +150.9% |
| CARRET ASSET MANAGEMENT, LLC | 70,000 | $81,900 | 0.63% | +58.7% |
| VANGUARD CAPITAL MANAGEMENT LLC | 68,109 | $79,688 | 0.61% | new |
| VANGUARD FIDUCIARY TRUST CO | 51,578 | $60,346 | 0.47% | new |
| RENAISSANCE TECHNOLOGIES LLC | 48,700 | $56,979 | 0.44% | +31.6% |
| PRUDENTIAL FINANCIAL INC | 28,000 | $32,760 | 0.25% | new |
| NORTHERN TRUST CORP | 20,519 | $24,007 | 0.18% | +0.0% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-13 | −$0.76 | — | $6.7M | +3.6% |
| 2025-12-31 | 2026-03-23 | — | — | $8.0M | −2.6% |
| 2025-09-30 | 2025-11-13 | −$1.59 | — | $7.4M | +21.3% |
| 2025-06-30 | 2025-08-14 | −$1.99 | — | $6.7M | −13.4% |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-12 is ESTIMATED from filing cadence (median gap 91d) — not company-confirmed.
Reportable 100%
business segments · each slice's share of TAGGED segment revenue in the latest annual filing (XBRL, as filed). Untagged revenue is excluded from the denominator, so slices need not sum to consolidated sales.
